These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21402310)

  • 21. The HIV Epidemic in South Africa: Key Findings from 2017 National Population-Based Survey.
    Zuma K; Simbayi L; Zungu N; Moyo S; Marinda E; Jooste S; North A; Nadol P; Aynalem G; Igumbor E; Dietrich C; Sigida S; Chibi B; Makola L; Kondlo L; Porter S; Ramlagan S; On Behalf Of The Sabssm V Study Group Contributors
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).
    Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Pillay D; Dabis F; Orne-Gliemann J;
    J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25128. PubMed ID: 30027600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.
    Herbst AJ; Cooke GS; Bärnighausen T; KanyKany A; Tanser F; Newell ML
    Bull World Health Organ; 2009 Oct; 87(10):754-62. PubMed ID: 19876542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.
    Hermans S; Boulle A; Caldwell J; Pienaar D; Wood R
    J Int AIDS Soc; 2015; 18(1):20240. PubMed ID: 26411694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis.
    Nanoo A; Izu A; Ismail NA; Ihekweazu C; Abubakar I; Mametja D; Madhi SA
    Lancet Infect Dis; 2015 Sep; 15(9):1066-1076. PubMed ID: 26112077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
    Cassim S; Antel K; Chetty DR; Oosthuizen J; Opie J; Mohamed Z; Verburgh E
    Pathology; 2020 Jun; 52(4):453-459. PubMed ID: 32305135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.
    van Harmelen J; Wood R; Lambrick M; Rybicki EP; Williamson AL; Williamson C
    AIDS; 1997 Jan; 11(1):81-7. PubMed ID: 9110079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.
    Abuelezam NN; McCormick AW; Fussell T; Afriyie AN; Wood R; DeGruttola V; Freedberg KA; Lipsitch M; Seage GR
    Am J Epidemiol; 2016 Aug; 184(3):239-48. PubMed ID: 27416841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Window Into the HIV Epidemic from a South African Emergency Department.
    Hansoti B; Stead D; Eisenberg A; Mvandaba N; Mwinnyaa G; Patel EU; Parrish A; Reynolds SJ; Redd AD; Fernandez R; Rothman RE; Laeyendecker O; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):139-144. PubMed ID: 30215268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.
    Pretorius C; Stover J; Bollinger L; Bacaër N; Williams B
    PLoS One; 2010 Nov; 5(11):e13646. PubMed ID: 21079767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human immunodeficiency virus and lymphoma].
    Tazi I; Lahlimi FZ
    Bull Cancer; 2021 Oct; 108(10):953-962. PubMed ID: 34246454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
    PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The arc of HIV epidemics in sub-Saharan Africa: new challenges with concentrating epidemics in the era of 90-90-90.
    Ortblad KF; Baeten JM; Cherutich P; Wamicwe JN; Wasserheit JN
    Curr Opin HIV AIDS; 2019 Sep; 14(5):354-365. PubMed ID: 31343457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.